Tech Company Financing Transactions
smartbax Funding Round
smartbax secured a $1.3 million Seed investment round on 5/23/2023. Investors included Boehringer Ingelheim Venture Fund and High-Tech Gründerfonds.
Transaction Overview
Company Name
Announced On
5/23/2023
Transaction Type
Venture Equity
Amount
$1,288,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to advance its small molecule antibiotics through preclinical studies, expand its scientific team to further develop its research platforms and identify novel solutions against multi-drug resistant pathogens.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Leopoldstraße 37
Munich, 80802
DE
Munich, 80802
DE
Phone
Website
Email Address
Overview
We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Macsics
Chief Operating Officer
Elisabeth Karg
Co-Founder
Stephan Sieber
Browse more venture capital transactions:
Prev: 5/23/2023: Mate Fertility venture capital transaction
Next: 5/23/2023: boombox.io venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs